Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Masako Shimojo"'
Autor:
Kumiko Tsuboi, Masako Shimojo, Toshiaki Tachibana, Kazutoshi Shibuya, Hajime Ueshiba, Hisashi Hashimoto, Mayumi Ishikawa, Gen Yoshino, Kazuhiro Kimura
Publikováno v:
Human Cell. 23:58-64
There are few case reports describing small cell lung carcinoma (SCLC), which secrete parathyroid hormone (PTH)-related protein (PTHrP) and result in hypercalcemia. We have established a novel cell line, derived from a 37-year-old woman with SCLC, wh
Autor:
Masako Shimojo, Kazuhiko Fujiki, Akira Ohwada, Mutsuko Yasuda, Ritsuko Joukyu, Fumiatsu Yakushiji, Yoshiyasu Terayama, Hiroshi Suzuki, Hiroyuki Kinoshita, Ken Taniguchi, Hiroshi Fujita, Kaoru Nagasawa
Publikováno v:
Diabetes Technology & Therapeutics. 11:369-372
Handheld blood glucose (BG) meters are convenient tools that are widely used to measure the BG levels. However, the hematocrit (Hct) value has been identified as a confounding factor for accurate BG measurement. Some BG meters are equipped with an Hc
Autor:
Kumiko Tsuboi, Masako Shimojo, Naoki Hiroi, Yukitaka Miyachi, Fumiatsu Yakushiji, Yusuke Shimizu, Hajime Ueshiba
Publikováno v:
European Journal of Endocrinology. :375-380
OBJECTIVE: To analyze activities of adrenal steroidogenic enzymes in type 2 diabetes mellitus, serum levels of 11 steroid hormones were measured simultaneously. SUBJECTS: We studied 130 patients with type 2 diabetes mellitus (74 men and 56 women betw
Autor:
Jenny Nobes, Iwona J. Bujalska, Márta Korbonits, Masako Shimojo, Suzanne Jordan, Paul M. Stewart, Ashley B. Grossman
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:2728-2733
One of the defining biochemical features of Cushing's disease is a relative insensitivity to glucocorticoid (GC) feedback, but an analysis of the GC receptor has failed to detect any major abnormalities. However, two isoenzymes of 11 beta-hydroxyster
Autor:
Martin Hewison, Massimiliano D. Petrelli, Gerald D. Johnson, Masako Shimojo, Alexander J. Howie, Arthur R. Bradwell, Paul M. Stewart, Phillip Moradi, M L Ricketts
Publikováno v:
Endocrinology. 138:1305-1311
11 beta-Hydroxysteroid dehydrogenase (11 beta HSI) is an enzyme complex responsible for the conversion of hormonally active cortisol to inactive cortisone; two isoforms of the enzyme have been cloned and characterized. Clinical observations from pati
Autor:
Fumiatsu, Yakushiji, Masako, Shimojo
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 68
Autor:
Mayumi, Ishikawa, Kazuhiro, Kimura, Toshiaki, Tachibana, Hisashi, Hashimoto, Masako, Shimojo, Hajime, Ueshiba, Kumiko, Tsuboi, Kazutoshi, Shibuya, Gen, Yoshino
Publikováno v:
Human cell. 23(2)
There are few case reports describing small cell lung carcinoma (SCLC), which secrete parathyroid hormone (PTH)-related protein (PTHrP) and result in hypercalcemia. We have established a novel cell line, derived from a 37-year-old woman with SCLC, wh
Autor:
Yoshiyasu Terayama, Jyunji Tomiyama, Kazuhiko Fujiki, Kaoru Nagasawa, Hiroshi Fujita, Hiroyuki Kinoshita, Fumiatsu Yakushiji, Mutsuko Yasuda, Ken Taniguchi, Masako Shimojo
Publikováno v:
Diabetes technologytherapeutics. 12(2)
Insulin injection pens have been primarily developed for self-injection among individuals with diabetes. However, an increased elderly population with diabetes has caused an increase in the number of patients who cannot self-inject insulin. Consequen
Publikováno v:
Journal of Chromatography B: Biomedical Sciences and Applications. 568:309-314
A method of determining a new angiotensin-converting enzyme inhibitor (CS-622) and its active metabolite (RS-5139) in plasma by inhibitor-binding assay has been developed using high-performance liquid chromatography. The assay is based on the princip
Autor:
Mayumi Ishikawa, Kaoru Nagasawa, Gen Yoshino, Masako Shimojo, Natsuko Watanabe, Kumiko Tsuboi, Rena Yuasa, Hajime Ueshiba
Publikováno v:
Endocrine journal. 54(1)
The relation between the incidence of methimazole (methylmercaptoimidazole; MMI)-induced agranulocytosis and initial MMI dose was evaluated in a group of 514 patients with Graves' disease who were treated between 1995 and 2005. One hundred and forty-